Study S002729

Metabolism-independent Vascular Effects of the Dipetidylpeptidase-4-inhibitor Sitagliptin in Patients With Type 2 Diabetes Mellitus

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT01096277
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: QUADRUPLE
Status: UNKNOWN
Enrollment: 70
Start: 2010-10
Primary completion: 2011-11
Lead sponsor: Hannover Medical School
Conditions: Type 2 Diabetes Mellitus
Interventions: DRUG:Sitagliptin; DRUG:Placebo; OTHER:Control
Results posted: FALSE
Secondary identifiers: OTHER:MHH_NPH_SS_1/2010

Registered primary outcomes

Endothelial function [Before and after two week treatment]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.